Takeda Pharmaceutical Company Limited
4502
Clasificación en acciones
#377
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Precio por acción
$40.31
Capitalización bursátil
$64.13B
Cambio (1 día)
0.82%
Cambio (1 año)
42.59%
País
JP
Comercio Takeda Pharmaceutical Company Limited (4502)
Categoría
Healthcare
Historial de rendimiento por dividendo de Takeda Pharmaceutical Company Limited (4502)
Rendimiento por dividendo (TTM) de Takeda Pharmaceutical Company Limited (símbolo bursátil: 4502) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Takeda Pharmaceutical Company Limited (4502) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
| Año | Rendimiento por dividendo | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Rendimientos por dividendo (TTM) de empresas similares o competidoras
| Empresa | Rendimiento por dividendo | País |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
|
| 0.00% |
CN
|
